adcs in lymphoma
Published 2 years ago • 20 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:13
antibody-drug conjugates for the treatment of lymphoma
-
2:07
adcs for aml: gemtuzumab ozogamicin
-
1:21
hodgkin lymphoma highlights from ash 2023: nivo-avd versus bv-avd in patients with hl
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:42
using cfdna to monitor and diagnose viral-associated lymphomas
-
0:55
the role of rna modifications in mds and aml
-
0:45
non-pharmaceutical interventions for patients with mpns and other hematological malignancies
-
7:52
린치증후군, 진단과 치료
-
3:24
pre-induction azacitidine and venetoclax to improve the bone marrow microenvironment in aml
-
1:38
molecular subtypes in diffuse large b-cell lymphoma
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:14
promising novel agents in aml: menin inhibitors
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:48
exciting lymphoma updates to expect at ash 2023
-
1:10
avenue: avelumab for classical hodgkin lymphoma
-
2:03
advances in pet & radiomics in lymphoma & insights into the international metabolic prognostic index
-
1:12
the evolving role of allosct in treatment of lymphoma